Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manlio Tolomeo

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 11, 2008
Synthesis and biological evaluation of 2-aroyl-4-phenyl-5-hydroxybenzofurans as a new class of antitubulin agentsRomeo Romagnoli, Pier Giovanni Baraldi, Taradas Sarkar, et al.
Archiv Der Pharmazie|May 6, 2009
N-(indazolyl)benzamido derivatives as CDK1 inhibitors: design, synthesis, biological activity, and molecular docking studiesDemetrio Raffa, Benedetta Maggio, Stella Cascioferro, et al.
International Immunopharmacology|January 23, 2003
Chemically modified tetracyclines induce cytotoxic effects against J774 tumour cell line by activating the apoptotic pathwayPietro D'Agostino, Viviana Ferlazzo, Salvatore Milano, et al.
Plos One|March 6, 2013
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cellsSilvia Turroni, Manlio Tolomeo, Gianfranco Mamone, et al.
European Journal of Medicinal Chemistry|December 7, 2010
Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activityBenedetta Maggio, Maria Valeria Raimondi, Demetrio Raffa, et al.
Cancer Letters|April 1, 2008
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cellsManlio Tolomeo, Stefania Grimaudo, Antonietta Di Cristina, et al.
BMC Pediatrics|November 25, 2011
Lymphocyte apoptosis in children with central nervous system tuberculosis: a case control studyPaola Di Carlo, Alessandra Casuccio, Amelia Romano, et al.
Bioorganic & Medicinal Chemistry Letters|August 19, 2014
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivativesRiccardo Rondanin, Daniele Simoni, Romeo Romagnoli, et al.
European Journal of Medicinal Chemistry|December 3, 2015
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylationRomeo Romagnoli, Pier Giovanni Baraldi, Filippo Prencipe, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activityElisa Giacomini, Angela Nebbioso, Alfonso Ciotta, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 11, 2008
Synthesis and biological evaluation of 2-aroyl-4-phenyl-5-hydroxybenzofurans as a new class of antitubulin agentsRomeo Romagnoli, Pier Giovanni Baraldi, Taradas Sarkar, et al.
Archiv Der Pharmazie|May 6, 2009
N-(indazolyl)benzamido derivatives as CDK1 inhibitors: design, synthesis, biological activity, and molecular docking studiesDemetrio Raffa, Benedetta Maggio, Stella Cascioferro, et al.
International Immunopharmacology|January 23, 2003
Chemically modified tetracyclines induce cytotoxic effects against J774 tumour cell line by activating the apoptotic pathwayPietro D'Agostino, Viviana Ferlazzo, Salvatore Milano, et al.
Plos One|March 6, 2013
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cellsSilvia Turroni, Manlio Tolomeo, Gianfranco Mamone, et al.
European Journal of Medicinal Chemistry|December 7, 2010
Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activityBenedetta Maggio, Maria Valeria Raimondi, Demetrio Raffa, et al.
Cancer Letters|April 1, 2008
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cellsManlio Tolomeo, Stefania Grimaudo, Antonietta Di Cristina, et al.
BMC Pediatrics|November 25, 2011
Lymphocyte apoptosis in children with central nervous system tuberculosis: a case control studyPaola Di Carlo, Alessandra Casuccio, Amelia Romano, et al.
Bioorganic & Medicinal Chemistry Letters|August 19, 2014
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivativesRiccardo Rondanin, Daniele Simoni, Romeo Romagnoli, et al.
European Journal of Medicinal Chemistry|December 3, 2015
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylationRomeo Romagnoli, Pier Giovanni Baraldi, Filippo Prencipe, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activityElisa Giacomini, Angela Nebbioso, Alfonso Ciotta, et al.
Pageof 8